Efficacy and Cost-effectiveness of Acceptance and Commitment Therapy and Applied Relaxation for Longstanding Pain A Randomized Controlled Trial

被引:51
|
作者
Kemani, Mike K. [1 ,2 ]
Olsson, Gunnar L. [1 ,3 ]
Lekander, Mats [2 ,4 ]
Hesser, Hugo [5 ]
Andersson, Erik [2 ]
Wicksell, Rikard K. [1 ,2 ]
机构
[1] Karolinska Univ Hosp, Behav Med Pain Treatment Serv, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
[4] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden
[5] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden
来源
CLINICAL JOURNAL OF PAIN | 2015年 / 31卷 / 11期
关键词
acceptance and commitment therapy (ACT); applied relaxation (AR); chronic pain; cost-effectiveness; COGNITIVE-BEHAVIORAL THERAPY; HEALTH SURVEY SF-36; CLINICAL-TRIALS; EXPOSURE TREATMENT; HOSPITAL ANXIETY; DISABILITY INDEX; VALIDITY; RELIABILITY; DEPRESSION; MEDIATORS;
D O I
10.1097/AJP.0000000000000203
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background and Objectives:To date, few studies have compared Acceptance and Commitment Therapy (ACT) for longstanding pain with established treatments. Only 1 study has evaluated the cost-effectiveness of ACT. The aim of the current study was to evaluate the efficacy and cost-effectiveness of ACT and applied relaxation (AR) for adults with unspecific, longstanding pain.Materials and Methods:On the basis of the inclusion criteria 60 consecutive patients received 12 weekly group sessions of ACT or AR. Data were collected pretreatment, midtreatment, and posttreatment, as well as at 3- and 6-month follow-up. Growth curve modeling was used to analyze treatment effects on pain disability, pain intensity, health-related quality of life (physical domain), anxiety, depression, and acceptance.Results:Significant improvements were seen across conditions (pretreatment to follow-up assessment) on all outcome measures. Pain disability decreased significantly in ACT relative to AR from preassessment to postassessment. A corresponding decrease in pain disability was seen in AR between postassessment and 6-month follow-up. Pain acceptance increased only in ACT, and this effect was maintained at 6-month follow-up. Approximately 20% of the participants achieved clinically significant change after treatment. Health economic analyses showed that ACT was more cost-effective than AR at post and 3-month follow-up assessment, but not at 6-month follow-up.Discussion:More studies investigating moderators and mediators of change are needed. The present study is one of few that have evaluated the cost-effectiveness of ACT and AR and compared ACT with an established behavioral intervention, and the results provide additional support for behavioral interventions for longstanding pain.
引用
收藏
页码:1004 / 1016
页数:13
相关论文
共 50 条
  • [1] The Effectiveness of Acceptance and Commitment Therapy on Pain Acceptance and Pain Perception in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial
    Taheri, Amir Abbas
    Foroughi, Ali Akbar
    Mohammadian, Youkhabeh
    Ahmadi, Seyed Mojtaba
    Heshmati, Khatereh
    Hezarkhani, Leila Afshar
    Parvizifard, Ali Akbar
    [J]. DIABETES THERAPY, 2020, 11 (08) : 1695 - 1708
  • [2] The Effectiveness of Acceptance and Commitment Therapy on Pain Acceptance and Pain Perception in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial
    Amir Abbas Taheri
    Ali Akbar Foroughi
    Youkhabeh Mohammadian
    Seyed Mojtaba Ahmadi
    Khatereh Heshmati
    Leila Afshar Hezarkhani
    Ali Akbar Parvizifard
    [J]. Diabetes Therapy, 2020, 11 : 1695 - 1708
  • [3] The effectiveness and cost-effectiveness of Acceptance and Commitment Therapy as a transdiagnostic intervention for transitional-age youth: study protocol of a randomized controlled trial
    Janna Keulen
    Denise Matthijssen
    Jacquelijne Schraven
    Maja Deković
    Denise Bodden
    [J]. BMC Psychiatry, 23
  • [4] The effectiveness and cost-effectiveness of Acceptance and Commitment Therapy as a transdiagnostic intervention for transitional-age youth: study protocol of a randomized controlled trial
    Keulen, Janna
    Matthijssen, Denise
    Schraven, Jacquelijne
    Dekovic, Maja
    Bodden, Denise
    [J]. BMC PSYCHIATRY, 2023, 23 (01)
  • [5] A randomized controlled effectiveness trial of acceptance and commitment therapy and cognitive therapy for anxiety and depression
    Forman, Evan M.
    Herbert, James D.
    Moitra, Ethan
    Yeomans, Peter D.
    Geller, Pamela A.
    [J]. BEHAVIOR MODIFICATION, 2007, 31 (06) : 772 - 799
  • [6] Acceptance and Commitment Therapy for Primary Headache Sufferers: A Randomized Controlled Trial of Efficacy
    Vasiliou, Vasilis S.
    Karademas, Evangelos C.
    Christou, Yiolanda
    Papacostas, Savvas
    Karekla, Maria
    [J]. JOURNAL OF PAIN, 2021, 22 (02): : 143 - 160
  • [7] Acceptance and commitment therapy for fibromyalgia: A randomized controlled trial
    Wicksell, R. K.
    Kemani, M.
    Jensen, K.
    Kosek, E.
    Kadetoff, D.
    Sorjonen, K.
    Ingvar, M.
    Olsson, G. L.
    [J]. EUROPEAN JOURNAL OF PAIN, 2013, 17 (04) : 599 - 611
  • [8] A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain
    Wetherell, Julie Loebach
    Afari, Niloofar
    Rutledge, Thomas
    Sorrell, John T.
    Stoddard, Jill A.
    Petkus, Andrew J.
    Solomon, Brittany C.
    Lehman, David H.
    Liu, Lin
    Lang, Ariel J.
    Atkinson, J. Hampton
    [J]. PAIN, 2011, 152 (09) : 2098 - 2107
  • [9] Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial
    Witlox, Maartje
    Kraaij, Vivian
    Garnefski, Nadia
    Bohlmeijer, Ernst
    Smit, Filip
    Spinhoven, Philip
    [J]. PLOS ONE, 2022, 17 (01):
  • [10] A randomized controlled trial of acceptance and commitment therapy for bipolar disorder
    Khafif, Tatiana
    Perez, William Ferreira
    Lafer, Beny
    [J]. BIPOLAR DISORDERS, 2023, 25 : 85 - 85